Pyrroloquinoline quinone scaffolds: centrality in anticancer drug design
Authors:
- 13 April 2026
- journal article
- review article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 18 (10) , 1285-1293
Abstract
1. Cancer presently ranks as the second foremost cause of global mortality, after heart disease [1]. In 2022, there were more than 20 million newly diagnosed cancer cases and 9.7 million fatalities...Keywords
This publication has 40 references indexed in Scilit:
- Pyrroloquinoline Quinone (PQQ): Its impact on human health and potential benefitsCurrent Research in Food Science, 2024
- Pyrroloquinoline Quinone Chemistry, Biology, and BiosynthesisChemical Research in Toxicology, 2022
- Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrationsArchives of Toxicology, 2020
- Pyrroloquinoline Quinine and LY294002 Changed Cell Cycle and Apoptosis by Regulating PI3K-AKT-GSK3β Pathway in SH-SY5Y CellsNeurotoxicity Research, 2020
- The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1Nature Communications, 2018
- Pyrroloquinoline Quinone Decelerates Rheumatoid Arthritis Progression by Inhibiting Inflammatory Responses and Joint Destruction via Modulating NF-κB and MAPK PathwaysInflammation, 2015
- MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translationNature Cell Biology, 2015
- The Catalysis of Redox Cycling by Pyrroloquinoline Quinone (PQQ), PQQ Derivatives, and Isomers and the Specificity of InhibitorsAnalytical Biochemistry, 1996
- Total synthesis of the novel coenyzme methoxatinThe Journal of Organic Chemistry, 1985
- Total synthesis of methoxatin, the coenzyme of methanol dehydrogenase and glucose dehydrogenaseThe Journal of Organic Chemistry, 1981